echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > After the Spring Festival, the Central Commission for Discipline Inspection issued a document naming medical and pharmaceutical corruption for the first time

    After the Spring Festival, the Central Commission for Discipline Inspection issued a document naming medical and pharmaceutical corruption for the first time

    • Last Update: 2021-03-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Medical News February 22 
     
    The Central Commission for Discipline Inspection issued a document to eradicate the soil for medical corruption
     
    On February 19, the National Supervision Commission of the Central Commission for Discipline Inspection published an article "Eradication of the Breeding Soil of Medical Corruption" on the important news section of the official website, again naming the issue of medical corruption.
     
    Taking the case of the First Affiliated Hospital of Wenzhou Medical University as an example, the article pointed out that since Zhou Moumou, the former party secretary and dean of the hospital, was expelled from the party and public office for illegally accepting property from others, the hospital's atmosphere has become better and better.
    , The doctor no longer collects red envelopes.
     
    As for the reason behind it is because after the review of the main body of the investigation, the task force took more than one month to investigate the corruption in the city's medical system.
    Through many on-site visits to relevant units, the staff of the Municipal Commission for Discipline Inspection and Supervision conducted face-to-face conversations with all members of the hospital and cadres at important positions, forming a strong deterrent.
     
    In addition, the annual reports of more than 290 listed pharmaceutical companies across the country were collected to analyze and interpret sales expenses.
    Finally, many management loopholes and blind spots in supervision were dug out, and they were targeted for in-depth rectification.
     
    It is not difficult to see that the Commission for Discipline Inspection and Supervision in some areas has begun to use a small number of key points to go to radiation to control the breeding soil of medical corruption, in order to achieve the goal of improving the ecology of the entire medical institution.
     
    The Central Commission for Discipline Inspection has commented in an earlier article that the investigation and handling of cases has played a role of warning and deterrence.
    At the same time, it is necessary to work hard on systems and governance, strengthen the restriction and supervision of the operation of power, and promote the construction of a multi-pronged comprehensive governance system.
     
      Entering February , many key few were investigated
     
      According to Cyberlan’s observations, the National Supervision Commission of the Central Commission for Discipline Inspection previously published an article on the official website of “Anti-corruption in the Medical Field: Someone Asks the Pulse with One Hand, and Swallows Gold in His Sleeve”, pointing out that hospital leaders such as the hospital director, as a key minority, are involved in many cases The problem.
     
      The article pointedly pointed out that one of the characteristics of corruption cases in the medical field is that the "key few" are involved in many cases, and the corruption of "top leaders" has become a typical feature.
    Some people regard hospitals as "private domains.
    "
     
      Indeed, since February, there have been news from many places that the hospital deans have been filed for investigation.
    According to incomplete statistics, as many as 6 deans have been "double-opened".
     
      On February 18, the Aba Prefecture Commission for Discipline Inspection and Supervision issued a message that: Gu Moumou, the former president of the Aba Prefecture People’s Hospital, was expelled from the party and public office for serious violations of discipline and law.
     
      The investigation found that Mr.
    Gu arbitrarily apportioned official reception drinks to suppliers of medical drugs , consumables and equipment; using the convenience of his position to seek benefits and receive property for others in the procurement of medical drugs, consumables and equipment, the amount was extremely large, etc.
    problem.
     
      Within a week before Gu was investigated, the chief of the General Affairs Section and the Director of the Pharmacy Section of the same hospital had been investigated.
     
      Also on February 18, the Shaanxi Provincial Commission for Discipline Inspection also announced that Gao Moumou, the former president of the Fourth People's Hospital of Shaanxi Province, had been "double-opened".
     
      According to the public announcement, Gao Moumou violated national laws and regulations, established and used small vaults for a long time, formed interest groups with illegal businessmen, used high-value medical consumables and unspoken rules in the procurement of medical equipment to collect money and collect wealth, suspected of corruption, bribery, and units.
    Bribery crime.
     
      Ministry of Finance: Insufficient compliance of capital activities of listed pharmaceutical companies
     
      It is not difficult to see that how many of the above-mentioned directors were investigated were related to the procurement of medicines and consumables.
    On October 17, 2020, the Central Commission for Discipline Inspection issued a headline bluntly that among the corruption cases in the medical field disclosed this year, the rebate of drug consumables has been charged the most frequently, showing that the amount involved in the case remains high and the chain of corruption interests is interlocking.
    This has caused problems such as inflated prices of medicines and medical consumables, excessively rapid growth of medical expenses, and massive loss of medical insurance funds, which have increased the burden on patients to seek medical care and infringed on the vital interests of the masses, and urgent rectification is required.
     
      Regarding the issue of drug rebates, the relevant person in charge of the Price Recruitment Department of the National Medical Insurance Bureau previously stated that according to the statistics of publicly available court judgments, from 2016 to 2019, more than half of the 100 compulsory drug companies in the country were found to have direct or indirect grants.
    Rebate behavior, among which the most frequent companies involved more than 20 cases in three years, the rebate amount in a single case exceeded 20 million yuan.
     
      On February 19, the Accounting Department of the Ministry of Finance issued the "Blue Book on the Implementation of the Corporate Internal Control Standard System by Listed Companies in 2019".
    It also pointed out that among the listed companies in the pharmaceutical manufacturing industry that disclosed major deficiencies and major deficiencies, the lack of corporate governance structure was exposed.
    Reasonable, insufficient internal supervision and control of subsidiaries, violations of related transaction operations and guarantees, and insufficient compliance of capital activities and financial accounting.
     
      From a business perspective, one is the non-compliance and lack of prudence in cash activities, guarantee business, and major investment decisions.
    Second, some listed companies in the pharmaceutical manufacturing industry have major deficiencies in financial accounting compliance, and there are deficiencies in the operation and financial information of individual businesses and projects.
     
      The improvement suggestions to promote the improvement of the internal control level and quality of listed companies in the pharmaceutical manufacturing industry include three aspects—strengthening the management and control of subsidiaries, strengthening the execution and management of internal control, and strengthening the preparation of financial reports.
     
      In the part of strengthening the preparation of financial reports, the Blue Book pointed out that it is necessary to strengthen the compliance of financial accounting to provide a basis for objectively, truthfully and completely reflecting the company's operating and financial status.
     
      The 2021 mission of the Central Commission for Discipline Inspection to rectify medical corruption
     
      Looking back at the second half of 2020, the National Health Commission and other departments have intensively released documents on the construction of medical style, announcing that they will carry out rectifications against red envelopes, rebates and other violations before the end of the year.
     
      After the phased rectification work has come to an end, on January 25, 2021, the Communiqué of the Fifth Plenary Meeting of the 19th Central Commission for Discipline Inspection of the Communist Party of China published on the 01th page of the People’s Daily made it clear that it will be deployed in the Central Commission for Discipline Inspection.
    The tasks for 2021 include: continuing to rectify corruption and unhealthy practices around the masses, and continuing to rectify corruption and work style issues in the fields of education and medical care, food and drug safety, law enforcement and justice.
     
      At the same time, as early as November 21, 2019, the National Health Commission expressed its decision to launch a new round of hospital inspections.
     
      A new round of inspections of large hospitals started in November 2019 and will be completed by the end of June 2022.
    The National Health Commission is responsible for the inspection of hospitals under the supervision of the commission.
    In principle, public hospitals above the second level are accepted for inspections.
    In principle, the number of inspection days for each hospital shall not be less than 7 days.
     
      According to incomplete statistics from Cyberlan, the health committees of Shanghai, Beijing, Liaoning, Shandong, Hebei and other provinces and cities have issued documents to carry out the implementation plan for large-scale hospital inspections in 2020-2022.
     
      According to the requirements of the national plan, inspections of large public hospitals should focus on hot issues, focusing on the implementation of the "Nine Prohibitions" of medical and health practices, such as billing commissions.
     
      It can be said that although 2021 has entered, inspections and rectifications for medical corruption will continue, and relevant medical practitioners must tighten the bottom line of business compliance.
    Medical News February 22 
     
      The Central Commission for Discipline Inspection issued a document to eradicate the soil for medical corruption
     
      On February 19, the National Supervision Commission of the Central Commission for Discipline Inspection published an article "Eradication of the Breeding Soil of Medical Corruption" on the important news section of the official website, again naming the issue of medical corruption.
     
      Taking the case of the First Affiliated Hospital of Wenzhou Medical University as an example, the article pointed out that since Zhou Moumou, the former party secretary and dean of the hospital, was expelled from the party and public office for illegally accepting property from others, the hospital's atmosphere has become better and better.
    , The doctor no longer collects red envelopes.
     
      As for the reason behind it is because after the review of the main body of the investigation, the task force took more than one month to investigate the corruption in the city's medical system.
    Through many on-site visits to relevant units, the staff of the Municipal Commission for Discipline Inspection and Supervision conducted face-to-face conversations with all members of the hospital and cadres at important positions, forming a strong deterrent.
     
      In addition, the annual reports of more than 290 listed pharmaceutical companies across the country were collected to analyze and interpret sales expenses.
    Finally, many management loopholes and blind spots in supervision were dug out, and they were targeted for in-depth rectification.
     
      It is not difficult to see that the Commission for Discipline Inspection and Supervision in some areas has begun to use a small number of key points to go to radiation to control the breeding soil of medical corruption, in order to achieve the goal of improving the ecology of the entire medical institution.
     
      The Central Commission for Discipline Inspection has commented in an earlier article that the investigation and handling of cases has played a role of warning and deterrence.
    At the same time, it is necessary to work hard on systems and governance, strengthen the restriction and supervision of the operation of power, and promote the construction of a multi-pronged comprehensive governance system.
     
      Entering February , many key few were investigated
     
      According to Cyberlan’s observations, the National Supervision Commission of the Central Commission for Discipline Inspection previously published an article on the official website of “Anti-corruption in the Medical Field: Someone Asks the Pulse with One Hand, and Swallows Gold in His Sleeve”, pointing out that hospital leaders such as the hospital director, as a key minority, are involved in many cases The problem.
     
      The article pointedly pointed out that one of the characteristics of corruption cases in the medical field is that the "key few" are involved in many cases, and the corruption of "top leaders" has become a typical feature.
    Some people regard hospitals as "private domains.
    "
     
      Indeed, since February, there have been news from many places that the hospital deans have been filed for investigation.
    According to incomplete statistics, as many as 6 deans have been "double-opened".
     
      On February 18, the Aba Prefecture Commission for Discipline Inspection and Supervision issued a message that: Gu Moumou, the former president of the Aba Prefecture People’s Hospital, was expelled from the party and public office for serious violations of discipline and law.
     
      The investigation found that Mr.
    Gu arbitrarily apportioned official reception drinks to suppliers of medical drugs , consumables and equipment; using the convenience of his position to seek benefits and receive property for others in the procurement of medical drugs, consumables and equipment, the amount was extremely large, etc.
    problem.
     
      Within a week before Gu was investigated, the chief of the General Affairs Section and the Director of the Pharmacy Section of the same hospital had been investigated.
     
      Also on February 18, the Shaanxi Provincial Commission for Discipline Inspection also announced that Gao Moumou, the former president of the Fourth People's Hospital of Shaanxi Province, had been "double-opened".
     
      According to the public announcement, Gao Moumou violated national laws and regulations, established and used small vaults for a long time, formed interest groups with illegal businessmen, used high-value medical consumables and unspoken rules in the procurement of medical equipment to collect money and collect wealth, suspected of corruption, bribery, and units.
    Bribery crime.
     
      Ministry of Finance: Insufficient compliance of capital activities of listed pharmaceutical companies
     
      It is not difficult to see that how many of the above-mentioned directors were investigated were related to the procurement of medicines and consumables.
    On October 17, 2020, the Central Commission for Discipline Inspection issued a headline bluntly that among the corruption cases in the medical field disclosed this year, the rebate of drug consumables has been charged the most frequently, showing that the amount involved in the case remains high and the chain of corruption interests is interlocking.
    This has caused problems such as inflated prices of medicines and medical consumables, excessively rapid growth of medical expenses, and massive loss of medical insurance funds, which have increased the burden on patients to seek medical care and infringed on the vital interests of the masses, and urgent rectification is required.
     
      Regarding the issue of drug rebates, the relevant person in charge of the Price Recruitment Department of the National Medical Insurance Bureau previously stated that according to the statistics of publicly available court judgments, from 2016 to 2019, more than half of the 100 compulsory drug companies in the country were found to have direct or indirect grants.
    Rebate behavior, among which the most frequent companies involved more than 20 cases in three years, the rebate amount in a single case exceeded 20 million yuan.
     
      On February 19, the Accounting Department of the Ministry of Finance issued the "Blue Book on the Implementation of the Corporate Internal Control Standard System by Listed Companies in 2019".
    It also pointed out that among the listed companies in the pharmaceutical manufacturing industry that disclosed major deficiencies and major deficiencies, the lack of corporate governance structure was exposed.
    Reasonable, insufficient internal supervision and control of subsidiaries, violations of related transaction operations and guarantees, and insufficient compliance of capital activities and financial accounting.
     
      From a business perspective, one is the non-compliance and lack of prudence in cash activities, guarantee business, and major investment decisions.
    Second, some listed companies in the pharmaceutical manufacturing industry have major deficiencies in financial accounting compliance, and there are deficiencies in the operation and financial information of individual businesses and projects.
     
      The improvement suggestions to promote the improvement of the internal control level and quality of listed companies in the pharmaceutical manufacturing industry include three aspects—strengthening the management and control of subsidiaries, strengthening the execution and management of internal control, and strengthening the preparation of financial reports.
     
      In the part of strengthening the preparation of financial reports, the Blue Book pointed out that it is necessary to strengthen the compliance of financial accounting to provide a basis for objectively, truthfully and completely reflecting the company's operating and financial status.
     
      The 2021 mission of the Central Commission for Discipline Inspection to rectify medical corruption
     
      Looking back at the second half of 2020, the National Health Commission and other departments have intensively released documents on the construction of medical style, announcing that they will carry out rectifications against red envelopes, rebates and other violations before the end of the year.
     
      After the phased rectification work has come to an end, on January 25, 2021, the Communiqué of the Fifth Plenary Meeting of the 19th Central Commission for Discipline Inspection of the Communist Party of China published on the 01th page of the People’s Daily made it clear that it will be deployed in the Central Commission for Discipline Inspection.
    The tasks for 2021 include: continuing to rectify corruption and unhealthy practices around the masses, and continuing to rectify corruption and work style issues in the fields of education and medical care, food and drug safety, law enforcement and justice.
     
      At the same time, as early as November 21, 2019, the National Health Commission expressed its decision to launch a new round of hospital inspections.
     
      A new round of inspections of large hospitals started in November 2019 and will be completed by the end of June 2022.
    The National Health Commission is responsible for the inspection of hospitals under the supervision of the commission.
    In principle, public hospitals above the second level are accepted for inspections.
    In principle, the number of inspection days for each hospital shall not be less than 7 days.
     
      According to incomplete statistics from Cyberlan, the health committees of Shanghai, Beijing, Liaoning, Shandong, Hebei and other provinces and cities have issued documents to carry out the implementation plan for large-scale hospital inspections in 2020-2022.
     
      According to the requirements of the national plan, inspections of large public hospitals should focus on hot issues, focusing on the implementation of the "Nine Prohibitions" of medical and health practices, such as billing commissions.
     
      It can be said that although 2021 has entered, inspections and rectifications for medical corruption will continue, and relevant medical practitioners must tighten the bottom line of business compliance.
    Medical News February 22 
     
      The Central Commission for Discipline Inspection issued a document to eradicate the soil for medical corruption
      The Central Commission for Discipline Inspection issued a document to eradicate the soil for medical corruption
     
      On February 19, the National Supervision Commission of the Central Commission for Discipline Inspection published an article "Eradication of the Breeding Soil of Medical Corruption" on the important news section of the official website, again naming the issue of medical corruption.
     
      Taking the case of the First Affiliated Hospital of Wenzhou Medical University as an example, the article pointed out that since Zhou Moumou, the former party secretary and dean of the hospital, was expelled from the party and public office for illegally accepting property from others, the hospital's atmosphere has become better and better.
    , The doctor no longer collects red envelopes.
     
      As for the reason behind it is because after the review of the main body of the investigation, the task force took more than one month to investigate the corruption in the city's medical system.
    Through many on-site visits to relevant units, the staff of the Municipal Commission for Discipline Inspection and Supervision conducted face-to-face conversations with all members of the hospital and cadres at important positions, forming a strong deterrent.
     
      In addition, the annual reports of more than 290 listed pharmaceutical companies across the country were collected to analyze and interpret sales expenses.
    Finally, many management loopholes and blind spots in supervision were dug out, and they were targeted for in-depth rectification.
     
      It is not difficult to see that the Commission for Discipline Inspection and Supervision in some areas has begun to use a small number of key points to go to radiation to control the breeding soil of medical corruption, in order to achieve the goal of improving the ecology of the entire medical institution.
     
      The Central Commission for Discipline Inspection has commented in an earlier article that the investigation and handling of cases has played a role of warning and deterrence.
    At the same time, it is necessary to work hard on systems and governance, strengthen the restriction and supervision of the operation of power, and promote the construction of a multi-pronged comprehensive governance system.
     
      Entering February , many key few were investigated
      Entering February , many key few were investigated
     
      According to Cyberlan’s observations, the National Supervision Commission of the Central Commission for Discipline Inspection previously published an article on the official website of “Anti-corruption in the Medical Field: Someone Asks the Pulse with One Hand, and Swallows Gold in His Sleeve”, pointing out that hospital leaders such as the hospital director, as a key minority, are involved in many cases The problem.
     
      The article pointedly pointed out that one of the characteristics of corruption cases in the medical field is that the "key few" are involved in many cases, and the corruption of "top leaders" has become a typical feature.
    Some people regard hospitals as "private domains.
    "
     
      Indeed, since February, there have been news from many places that the hospital deans have been filed for investigation.
    According to incomplete statistics, as many as 6 deans have been "double-opened".
     
      On February 18, the Aba Prefecture Commission for Discipline Inspection and Supervision issued a message that: Gu Moumou, the former president of the Aba Prefecture People’s Hospital, was expelled from the party and public office for serious violations of discipline and law.
     
      The investigation found that Mr.
    Gu arbitrarily apportioned official reception drinks to suppliers of medical drugs , consumables and equipment; using the convenience of his position to seek benefits and receive property for others in the procurement of medical drugs, consumables and equipment, the amount was extremely large, etc.
    problem.
    Medicine, medicine, medicine
     
      Within a week before Gu was investigated, the chief of the General Affairs Section and the Director of the Pharmacy Section of the same hospital had been investigated.
     
      Also on February 18, the Shaanxi Provincial Commission for Discipline Inspection also announced that Gao Moumou, the former president of the Fourth People's Hospital of Shaanxi Province, had been "double-opened".
     
      According to the public announcement, Gao Moumou violated national laws and regulations, established and used small vaults for a long time, formed interest groups with illegal businessmen, used high-value medical consumables and unspoken rules in the procurement of medical equipment to collect money and collect wealth, suspected of corruption, bribery, and units.
    Bribery crime.
    Medical equipment medical equipment medical equipment
     
      Ministry of Finance: Insufficient compliance of capital activities of listed pharmaceutical companies
      Ministry of Finance: Insufficient compliance of capital activities of listed pharmaceutical companies
     
      It is not difficult to see that how many of the above-mentioned directors were investigated were related to the procurement of medicines and consumables.
    On October 17, 2020, the Central Commission for Discipline Inspection issued a headline bluntly that among the corruption cases in the medical field disclosed this year, the rebate of drug consumables has been charged the most frequently, showing that the amount involved in the case remains high and the chain of corruption interests is interlocking.
    This has caused problems such as inflated prices of medicines and medical consumables, excessively rapid growth of medical expenses, and massive loss of medical insurance funds, which have increased the burden on patients to seek medical care and infringed on the vital interests of the masses, and urgent rectification is required.
     
      Regarding the issue of drug rebates, the relevant person in charge of the Price Recruitment Department of the National Medical Insurance Bureau previously stated that according to the statistics of publicly available court judgments, from 2016 to 2019, more than half of the 100 compulsory drug companies in the country were found to have direct or indirect grants.
    Rebate behavior, among which the most frequent companies involved more than 20 cases in three years, the rebate amount in a single case exceeded 20 million yuan.
    Enterprise business enterprise
     
      On February 19, the Accounting Department of the Ministry of Finance issued the "Blue Book on the Implementation of the Corporate Internal Control Standard System by Listed Companies in 2019".
    It also pointed out that among the listed companies in the pharmaceutical manufacturing industry that disclosed major deficiencies and major deficiencies, the lack of corporate governance structure was exposed.
    Reasonable, insufficient internal supervision and control of subsidiaries, violations of related transaction operations and guarantees, and insufficient compliance of capital activities and financial accounting.
    Medicine Medicine Medicine
     
      From a business perspective, one is the non-compliance and lack of prudence in cash activities, guarantee business, and major investment decisions.
    Second, some listed companies in the pharmaceutical manufacturing industry have major deficiencies in financial accounting compliance, and there are deficiencies in the operation and financial information of individual businesses and projects.
     
      The improvement suggestions to promote the improvement of the internal control level and quality of listed companies in the pharmaceutical manufacturing industry include three aspects—strengthening the management and control of subsidiaries, strengthening the execution and management of internal control, and strengthening the preparation of financial reports.
     
      In the part of strengthening the preparation of financial reports, the Blue Book pointed out that it is necessary to strengthen the compliance of financial accounting to provide a basis for objectively, truthfully and completely reflecting the company's operating and financial status.
     
      The 2021 mission of the Central Commission for Discipline Inspection to rectify medical corruption
     
      Looking back at the second half of 2020, the National Health Commission and other departments have intensively released documents on the construction of medical style, announcing that they will carry out rectifications against red envelopes, rebates and other violations before the end of the year.
     
      After the phased rectification work has come to an end, on January 25, 2021, the Communiqué of the Fifth Plenary Meeting of the 19th Central Commission for Discipline Inspection of the Communist Party of China published on the 01th page of the People’s Daily made it clear that it will be deployed in the Central Commission for Discipline Inspection.
    The tasks for 2021 include: continuing to rectify corruption and unhealthy practices around the masses, and continuing to rectify corruption and work style issues in the fields of education and medical care, food and drug safety, law enforcement and justice.
     
      At the same time, as early as November 21, 2019, the National Health Commission expressed its decision to launch a new round of hospital inspections.
    Hospital hospital hospital
     
      A new round of inspections of large hospitals started in November 2019 and will be completed by the end of June 2022.
    The National Health Commission is responsible for the inspection of hospitals under the supervision of the commission.
    In principle, public hospitals above the second level are accepted for inspections.
    In principle, the number of inspection days for each hospital shall not be less than 7 days.
     
      According to incomplete statistics from Cyberlan, the health committees of Shanghai, Beijing, Liaoning, Shandong, Hebei and other provinces and cities have issued documents to carry out the implementation plan for large-scale hospital inspections in 2020-2022.
     
      According to the requirements of the national plan, inspections of large public hospitals should focus on hot issues, focusing on the implementation of the "Nine Prohibitions" of medical and health practices, such as billing commissions.
     
      It can be said that although 2021 has entered, inspections and rectifications for medical corruption will continue, and relevant medical practitioners must tighten the bottom line of business compliance.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.